about
AMP-activated protein kinase plays a role in the control of food intakeInactivation of aconitase and oxoglutarate dehydrogenase in skeletal muscle in vitro by superoxide anions and/or nitric oxideNew developments in treating glycosphingolipid storage diseases.Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women.Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change.Physiological, biochemical, anthropometric, and biomechanical influences on exercise economy in humans.Metabolism and Whole-Body Fat Oxidation Following Postexercise Carbohydrate or Protein Intake.Pregnancy to postpartum transition of serum metabolites in women with gestational diabetes.Whole-body fat oxidation increases more by prior exercise than overnight fasting in elite endurance athletes.Higher Concentrations of BCAAs and 3-HIB Are Associated with Insulin Resistance in the Transition from Gestational Diabetes to Type 2 Diabetes.Circulating Linoleic Acid is Associated with Improved Glucose Tolerance in Women after Gestational DiabetesN-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivoLongitudinal changes in adipokines and free leptin index during and after pregnancy in women with obesityMaternal obesity and gestational diabetes mellitus affect body composition through infancy: the PONCH studyAdipose tissue and body composition in women six years after gestational diabetes: factors associated with development of type 2 diabetes
P50
Q28240521-AC06C55E-FAE4-418B-8031-0B55980DF62AQ28570945-EFE4358D-4AB5-407E-A4AF-2AAB05A731D7Q36363837-23B85355-9091-4E5C-A31C-8D6820E5BB6BQ38292655-EADA1C67-4CAF-4539-B29F-86D498F41EF5Q44751969-140143F3-E4FF-40A5-B739-6DA9D219A6FEQ44985232-F183A9F2-4E3C-4EA9-B88C-AB593B7578A3Q47176117-6178CBD6-DED6-4DCA-A45F-D1E4D611864EQ47334040-5393AFF3-7B13-4009-BADC-CE14A2446EA8Q47856039-F61C2719-5D52-429A-BF43-9B12BCF8E215Q50568974-393B1505-D30D-4923-80B0-BA46A2FA7996Q51287212-17A7391B-2D02-41CC-A722-CCA7720E3DF0Q55422079-9E839B09-3D23-488E-83DF-CD7416C5FC6CQ58617694-4ED2974A-5527-4321-AC20-5E08C34A94BEQ62403498-800F283E-C343-4E0E-AEB3-EBB30F52899CQ90262231-2907B8B0-7C1D-4C7D-9591-24AFC0D8A65EQ91297668-61016823-BADB-4B08-B1E2-950EEB221A81Q91675984-9508947E-FEC9-4894-951C-9EC221A80D87
P50
description
researcher ORCID ID = 0000-0003-3722-3454
@en
wetenschapper
@nl
name
Ulrika Andersson Hall
@ast
Ulrika Andersson Hall
@en
Ulrika Andersson Hall
@es
Ulrika Andersson Hall
@nl
type
label
Ulrika Andersson Hall
@ast
Ulrika Andersson Hall
@en
Ulrika Andersson Hall
@es
Ulrika Andersson Hall
@nl
prefLabel
Ulrika Andersson Hall
@ast
Ulrika Andersson Hall
@en
Ulrika Andersson Hall
@es
Ulrika Andersson Hall
@nl
P31
P496
0000-0003-3722-3454